| |
|
|
|
GTC Conference, San Francisco, CA, Hotel Kabuki
Sep 22-23, 2011
The 4th CNS Partnering & Deal Making Conference is a CNS Diseases partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS Disease issues and partnerships that will affect the industry.
This event also provides a unique venue for attendees to learn about CNS Diseases business development trends, the CNS disease market, and novel technologies that shape up the industry.
|
|
|
|
|
|
|
|
Organized by:
|
|
GTC Conference |
|
|
Invited Speakers:
|
|
Joseph Araujo
Vice President and CFO
CanCog Technologies
Raymond T. Bartus
Executive Vice President and Chief Scientific Officer
Ceregene
Kees Been
President and CEO
EnVivo Pharmaceuticals
Jens Bitsch-Norhave
Director, Business Licensing, PGBD
Johnson&Johnson c/o Janssen Pharmaceutica
Christine de los Reyes
Founder and Managing Director
BiotechPartnering Solutions, LLC
Klaus D. Mendla
Global Head, CNS Business Development and Licensing
Boehringer Ingelheim Pharma GmbH & Co. KG
Lubor Gaal
Executive Director, Neuroscience, Strategic Transactions Group
Bristol-Myers Squibb
Marcie Glicksman
Co-Director Laboratory for Drug Discovery
Brigham and Women's Hospital
Timothy Herpin
Director, Strategic Transactions Group
Bristol-Myers Squibb
Manuel O. Lopez-Figueroa
Vice President
Bay City Capital; Pritzker Neuropsychiatric Disorders Research Consortium
Deborah Rathjen
CEO & Managing Director
Bionomics
Anna Rivkin
Associate Director, Scientific Liaison for CNS
Merck
Luca Santarelli
Global Head of CNS
Roche
Alexander Schuth
Senior Financial Analyst, Business Development
Genentech
Bavani Shankar
Vice President, Corporate Development
PsychoGenics Inc.
Michael M. Shih
Senior Director, Business Development
Eisai Inc.
Shafique Virani
Global Head CNS Business Development & Licensing
F. Hoffmann-La Roche LTD
Yue Wang
Head, Electrophysiology Facility
NIA/NIH
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
August 22, 2011
|
|
|
|
|
|
|
|
Registration:
|
|
https://www.gtcbio.com/index.php?option=com_register&cn=4th%20CNS%20Partnering%20and%20Deal-making&cid=38
|
|
|
E-mail:
|
|
infogtcbio@gtcbio.com
|
|
|
|
|
|
|
|
|